Narcolepsy Drugs Market - Top Companies and Manufacturers

  • Report ID: 2767
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Companies Dominating the Narcolepsy Drugs Landscape

    • Ligand Pharmaceuticals Incorporated 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Jazz Pharmaceuticals Inc.
    • Graymark Healthcare Inc.
    • BIOPROJET
    • Novartis AG
    • Teva Pharmaceuticals Industries Ltd.
    • Arena Pharmaceuticals Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Ligand Pharmaceuticals Incorporated and GSK declared the Licence Agreement and the global growth of their relationship. The development is expected to be fueled by Icagen's particle discovery method and expertise in small-molecule therapeutics addressing membrane proteins.
  • Teva Pharmaceutical Industries Ltd. stated that they would spend USD 69 million to settle a Narcolepsy drug lawsuit in California. The reimbursement is expected to help the corporation in maintaining its monopoly in an industry where the rival corporation's Narcolepsy drugs will postpone their release by nearly six months.

Author Credits:  Radhika Pawar


  • Report ID: 2767
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of narcolepsy drugs is evaluated at USD 3.96 Billion.

The narcolepsy drugs market size was valued at USD 3.63 Billion in 2023 and is projected to exceed USD 12.68 Billion by 2036, expanding at over 10.1% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of narcolepsy globally owing to the stressful lifestyle along with the surge in consumption of alcohol and tobacco is one of the major factors estimated to drive the growth of market.

North America industry is expected to have the highest growth through 2036, owing to rising prevalence of unhealthy lifestyles along with the technological advancements for the diagnosis of disease.

Ligand Pharmaceuticals Incorporated, Jazz Pharmaceuticals Inc., Graymark Healthcare Inc., BIOPROJET, Novartis AG, Teva Pharmaceuticals Industries Ltd., Arena Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample